2019 biotech IPOs: party on
2020
Continued VC largesse and a maturing biotech industry in China helped boost 2019’s IPO totals. Continued VC largesse and a maturing biotech industry in China helped boost 2019’s IPO totals.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI